Despite previous scientific studies that suggest diabetes drug metformin has anti-cancer properties, a new, first-of-its-kind study has found the drug may not actually improve survival rates after breast cancer in certain patients.
Despite previous scientific studies that suggest diabetes drug metformin has anti-cancer properties, a new, first-of-its-kind study has found the drug may not actually improve survival rates after breast cancer in certain patients.